Washington, Jan 25, 2022 -Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up…
By Ludwig Burger and Michael Erman – BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a…
By Ludwig Burger FRANKFURT, – BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how…
By David Shepardson and John Chalmers WASHINGTON/PARIS: The United States ordered airlines to hand over the names of passengers from southern African countries hit by the Omicron COVID-19 variant and…
The emergence of the new omicron variant and the world’s desperate and likely futile attempts to keep it at bay are reminders of what scientists have warned for months: The…
DAKAR: Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which produces…
BEIJING: Shanghai-based Everest Medicines said it signed a licence agreement with Providence Therapeutics to make and sell the Canadian biotechnology company’s potential mRNA COVID vaccines in some Asian countries including…
